Origami Therapeutics, Inc. YC 申请
Origami Therapeutics, Inc. 在 Winter 2022 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2022
- 行业
- HealthcareTherapeutics
- 团队规模
- 4
- 状态
- Active
- 已发布
- 2022
创始人
Beth HoffmanFounder
Origami Therapeutics, Inc. 做什么
Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified small molecules that reduce the toxic mutated protein, suppress mutant protein-induced toxicities in human disease neurons and get into the brain. We anticipate that this approach will be broadly applicable to traditionally “undruggable” targets in other neurological diseases.
Origami Therapeutics, Inc. 的 YC 申请，重建版
Y Combinator 申请
Origami Therapeutics, Inc.，Winter 2022 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Origami Therapeutics, Inc.
Oral drugs to halt neurodegeneration
We develop oral small molecule protein degraders aimed at halting neurodegeneration by removing toxic proteins that cause diseases like Huntington's. We use proprietary human disease models to select molecules that get into the brain and reduce mutant proteins in neurons.
We live in San Diego, CA and will be based here after YC.
San Diego's biotech ecosystem and access to scientific talent fit our development timeline and goals.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。
常见问题解答
这是 Origami Therapeutics, Inc. 的真实 YC 申请吗？
不是。Y Combinator 对提交的申请保密。这是重建版：使用 Origami Therapeutics, Inc. 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Origami Therapeutics, Inc. 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。
Origami Therapeutics, Inc. 是哪个 YC 批次的？
Origami Therapeutics, Inc. 是 Y Combinator Winter 2022 批次的成员。
谁创立了 Origami Therapeutics, Inc.？
Origami Therapeutics, Inc. 由 Beth Hoffman 创立。
Origami Therapeutics, Inc. 做什么？
Oral drugs to halt neurodegeneration
如何阅读完整的重建申请？
创建免费的 Round Funded 账户。YC Insights 中包含 Origami Therapeutics, Inc. 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。
更多 YC 初创公司，例如 Origami Therapeutics, Inc.
